title: Rapid and accurate determination of the potency of varicella vaccine by quantitative polymerase chain reaction.
abstract: The potency of varicella vaccines is currently determined by a plaque assay technique, which usually takes seven days and is laborious and has considerable inter- and intra-assay variability. Here, we report a new potency assay for varicella vaccine based on quantitative polymerase chain reaction in conjunction with a much more efficient virus infection step. Potency results can be obtained within 24h of infection and demonstrates acceptable accuracy and reproducibility when compared with the plaque assay, which relies on manual counting of plaques formed one week after viral infection. Using multiple vaccine lots from 7 manufacturers, we found no significant difference in infectivity determined between the new assay and plaque assay. The optimized conditions for viral infection and polymerase chain reaction are of significant value for the potency determination of the vaccine due to its rapidity, accuracy and the high throughput capacity of the assay.
authors.affiliation: Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, Health Canada, Ottawa, Canada.
authors.forename: Marsha S
authors.initials: MS
authors.lastname: Russell
authors.forename: Changgui
authors.initials: C
authors.lastname: Li
authors.forename: Louise
authors.initials: L
authors.lastname: Larocque
authors.forename: Junzhi
authors.initials: J
authors.lastname: Wang
authors.forename: Aaron
authors.initials: A
authors.lastname: Farnsworth
authors.forename: Runtao
authors.initials: R
authors.lastname: He
authors.forename: Xuguang
authors.initials: X
authors.lastname: Li
mesh_terms: D019433:Chickenpox Vaccine / Q000235:genetics / Q000276:immunology* / Q000592:standards*; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods*; D011786:Quality Control; D013678:Technology, Pharmaceutical / Q000379:methods*
chemical_list: D019433:Chickenpox Vaccine